Search research articles
Contact Us
Filters
Showing results (11-20 of 114) with videos related to
Page
of 12
Sort By:
Oncology (Williston Park, N.Y.)
|
May 12, 2004
Patient selection for prostate brachytherapy: more myth than fact
Gregory S Merrick, Kent E Wallner, Wayne M Butler
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2003
Comparison of MRI pulse sequences in defining prostate volume after permanent implantation: in regard to McLaughlin et al., IJROBP 2002;54:703-711
Gregory S Merrick, Wayne M Butler, Kent E Wallner
Brachytherapy
|
April 29, 2006
Commentary on "Medical malpractice in the age of technology: how specialty societies can make a difference (Anscher and Anscher)"
Kent E Wallner, Kathryn Elliott, Gregory S Merrick, et al.
Oncology (Williston Park, N.Y.)
|
September 10, 2008
Interstitial brachytherapy should be standard of care for treatment of high-risk prostate cancer
Nathan Bittner, Gregory S Merrick, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2003
Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Oncology (Williston Park, N.Y.)
|
June 3, 2006
Permanent prostate brachytherapy: is supplemental external-beam radiation therapy necessary?
Gregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 16, 2025
Beyond the Beam: Redefining Survivorship in Prostate Cancer
Mutlay Sayan, Grgur Mirić, Kent E Wallner, et al.
Cancer Journal (Sudbury, Mass.)
|
August 3, 2004
Treatment margins predict biochemical outcomes after prostate brachytherapy
Seungtaek Choi, Kent E Wallner, Gregory S Merrick, et al.
American Journal of Clinical Oncology
|
December 4, 2004
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mL
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy
|
November 4, 2015
Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease?
Gregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 114) with videos related to
Sort By:
Page
of 12
Oncology (Williston Park, N.Y.)
|
May 12, 2004
Patient selection for prostate brachytherapy: more myth than fact
Gregory S Merrick, Kent E Wallner, Wayne M Butler
International Journal of Radiation Oncology, Biology, Physics
|
June 6, 2003
Comparison of MRI pulse sequences in defining prostate volume after permanent implantation: in regard to McLaughlin et al., IJROBP 2002;54:703-711
Gregory S Merrick, Wayne M Butler, Kent E Wallner
Brachytherapy
|
April 29, 2006
Commentary on "Medical malpractice in the age of technology: how specialty societies can make a difference (Anscher and Anscher)"
Kent E Wallner, Kathryn Elliott, Gregory S Merrick, et al.
Oncology (Williston Park, N.Y.)
|
September 10, 2008
Interstitial brachytherapy should be standard of care for treatment of high-risk prostate cancer
Nathan Bittner, Gregory S Merrick, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2003
Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Oncology (Williston Park, N.Y.)
|
June 3, 2006
Permanent prostate brachytherapy: is supplemental external-beam radiation therapy necessary?
Gregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 16, 2025
Beyond the Beam: Redefining Survivorship in Prostate Cancer
Mutlay Sayan, Grgur Mirić, Kent E Wallner, et al.
Cancer Journal (Sudbury, Mass.)
|
August 3, 2004
Treatment margins predict biochemical outcomes after prostate brachytherapy
Seungtaek Choi, Kent E Wallner, Gregory S Merrick, et al.
American Journal of Clinical Oncology
|
December 4, 2004
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mL
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy
|
November 4, 2015
Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease?
Gregory S Merrick, Kent E Wallner, Robert W Galbreath, et al.
Page
of 12